Oxazolidinones as novel human CCR8 antagonists

Jian Jin, Yonghui Wang, Feng Wang, Jeffery K. Kerns, Victoria M. Vinader, Ashley P. Hancock, Matthew J. Lindon, Graeme I. Stevenson, Dwight M. Morrow, Parvathi Rao, Cuc Nguyen, Victoria J. Barrett, Chris Browning, Guido Hartmann, David P. Andrew, Henry M. Sarau, James J. Foley, Anthony J. Jurewicz, James A. Fornwald, Andy J. HarkerMichael L. Moore, Ralph A. Rivero, Kristen E. Belmonte, Helen E. Connor

Research output: Contribution to journalArticlepeer-review

23 Scopus citations

Abstract

High-throughput screening of the corporate compound collection led to the discovery of a novel series of N-substituted-5-aryl-oxazolidinones as potent human CCR8 antagonists. The synthesis, structure-activity relationships, and optimization of the series that led to the identification of SB-649701 (1a), are described.

Original languageEnglish
Pages (from-to)1722-1725
Number of pages4
JournalBioorganic and Medicinal Chemistry Letters
Volume17
Issue number6
DOIs
StatePublished - 15 Mar 2007
Externally publishedYes

Keywords

  • Antagonists
  • Asthma
  • CCR8
  • Chemokine receptors
  • HIV
  • N-substituted-5-aryl-oxazolidinones

Fingerprint

Dive into the research topics of 'Oxazolidinones as novel human CCR8 antagonists'. Together they form a unique fingerprint.

Cite this